Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N9PY
|
||||
| Former ID |
DNC004693
|
||||
| Drug Name |
3-[5-Ethoxy-indan-(1E)-ylidenemethyl]-pyridine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527456] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C17H17NO
|
||||
| Canonical SMILES |
CCOC1=CC2=C(C=C1)C(=CC3=CN=CC=C3)CC2
|
||||
| InChI |
1S/C17H17NO/c1-2-19-16-7-8-17-14(5-6-15(17)11-16)10-13-4-3-9-18-12-13/h3-4,7-12H,2,5-6H2,1H3/b14-10+
|
||||
| InChIKey |
PXXLKRIIKURDBT-GXDHUFHOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527456] | |
| Cytochrome P450 19 | Target Info | Inhibitor | [527456] | ||
| NetPath Pathway | FSH Signaling Pathway | ||||
| PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
| PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
| WikiPathways | Metapathway biotransformation | ||||
| Oxidation by Cytochrome P450 | |||||
| Metabolism of steroid hormones and vitamin D | |||||
| Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
| Tryptophan metabolism | |||||
| Ovarian Infertility Genes | |||||
| FSH signaling pathway | |||||
| Integrated Breast Cancer Pathway | |||||
| Phase 1 - Functionalization of compounds | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.